Continuing Medical Education for Dermatology | Earn Free CME Credits

Search

All France Foundation Content

Results 1 - 49 of 49

Rapid Recap: Immunology’s Role in GPP Pathogenesis and Therapy

The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy

A Focus on Fabry Disease: An EXPLORE™ eLearning Module

Am I Treating My Patients With Psoriatic Disease Effectively?

Am I Treating My Patients with Psoriatic Disease Effectively?

Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs

Practical Applications From What We Heard at Virtual ACR

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

New Directions in the Diagnosis of RA ILD

Therapies on the Horizon for RA ILD

New Treatment Options for SSc ILD

Updates on Current Treatment Options for RA ILD

Biochemical Profiles of Radiographic Patterns in SSc-ILD

Factors Associated with Disease Progression in the SENSCIS Trial

Machine Learning Assisted Prediction of Progression in SSc-ILD

What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD

Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD

Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis

Updates on Current Treatment Options for RA-ILD

Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

What's New in Advanced CSCC Care

The Evidence So Far: Risk, Referral, and What's New in Advanced CSCC Care

Atopic Dermatitis: Diagnosis and Management in Infants and Children

Updates in Atopic Dermatitis: Diagnosis and Management in Adults

Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child

Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Adult

Atopic Dermatitis: Putting it Together (Dermatology)

Atopic Dermatitis: Putting it Together (Primary Care)

atopic-derm2 copy

Atopic Dermatitis: Recent and Emerging Therapies

An Introduction to Atopic Dermatitis

biosims-archmed icon23

Top Questions about Biosimilars in Dermatology

psoriasis-nurse

Psoriasis Management Considerations: What Would You Do?

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Switching Between Biologics: Is a Biosimilar an Option?

When to Switch? Biologically Experienced Psoriasis Patients

Innovator or Biosimilar for a Patient with Psoriasis

Interchangeability and Pharmacy-Level Substitution

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

Sorting it Out: Biologics, Biosimilars, Small Molecule Drugs, and Generics

Health Care Providers’ Perspectives on Biosimilars: Based in Fact or Not?

Pharmacovigilance and Biosimilars: Any Special Considerations?

Interchangeability and Biosimilars: What will this Mean for Clinical Practice?

Can a Biosimilar be Used for the Same Indications Approved for the Reference Biologic?

Biosimilars: As Safe and Effective as the Reference Product?

Drift and the Manufacturing of Biologics: What is it and Does it Matter?

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA